These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 33403396)
1. Glyco-engineered HEK 293-F cell lines for the production of therapeutic glycoproteins with human N-glycosylation and improved pharmacokinetics. Uhler R; Popa-Wagner R; Kröning M; Brehm A; Rennert P; Seifried A; Peschke M; Krieger M; Kohla G; Kannicht C; Wiedemann P; Hafner M; Rosenlöcher J Glycobiology; 2021 Aug; 31(7):859-872. PubMed ID: 33403396 [TBL] [Abstract][Full Text] [Related]
2. Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles. Amann T; Hansen AH; Kol S; Hansen HG; Arnsdorf J; Nallapareddy S; Voldborg B; Lee GM; Andersen MR; Kildegaard HF Metab Eng; 2019 Mar; 52():143-152. PubMed ID: 30513349 [TBL] [Abstract][Full Text] [Related]
3. Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells. Böhm E; Seyfried BK; Dockal M; Graninger M; Hasslacher M; Neurath M; Konetschny C; Matthiessen P; Mitterer A; Scheiflinger F BMC Biotechnol; 2015 Sep; 15():87. PubMed ID: 26382581 [TBL] [Abstract][Full Text] [Related]
4. Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice. Huang G; Li Z; Li Y; Liu G; Sun S; Gu J; Kameyama A; Li W; Dong W Biochem J; 2020 Mar; 477(6):1179-1201. PubMed ID: 32141499 [TBL] [Abstract][Full Text] [Related]
5. Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells. Rodrigues JG; Duarte HO; Gomes C; Balmaña M; Martins ÁM; Hensbergen PJ; de Ru AH; Lima J; Albergaria A; van Veelen PA; Wuhrer M; Gomes J; Reis CA Cell Oncol (Dordr); 2021 Aug; 44(4):835-850. PubMed ID: 33847896 [TBL] [Abstract][Full Text] [Related]
6. Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4. Fiete D; Beranek M; Baenziger JU J Biol Chem; 2012 Aug; 287(34):29204-12. PubMed ID: 22722940 [TBL] [Abstract][Full Text] [Related]
7. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression. Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927 [TBL] [Abstract][Full Text] [Related]
8. Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation. Zhou X; Kinlough CL; Hughey RP; Jin M; Inoue H; Etling E; Modena BD; Kaminski N; Bleecker ER; Meyers DA; Jarjour NN; Trudeau JB; Holguin F; Ray A; Wenzel SE JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30730306 [TBL] [Abstract][Full Text] [Related]
9. Rapid clearance of sialylated glycoproteins by the asialoglycoprotein receptor. Park EI; Manzella SM; Baenziger JU J Biol Chem; 2003 Feb; 278(7):4597-602. PubMed ID: 12464602 [TBL] [Abstract][Full Text] [Related]
10. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes. Son YD; Jeong YT; Park SY; Kim JH Glycobiology; 2011 Aug; 21(8):1019-28. PubMed ID: 21436238 [TBL] [Abstract][Full Text] [Related]
11. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane. Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258 [TBL] [Abstract][Full Text] [Related]
12. O-linked glycosylation of the mucin domain of the herpes simplex virus type 1-specific glycoprotein gC-1 is temporally regulated in a seed-and-spread manner. Nordén R; Halim A; Nyström K; Bennett EP; Mandel U; Olofsson S; Nilsson J; Larson G J Biol Chem; 2015 Feb; 290(8):5078-5091. PubMed ID: 25548287 [TBL] [Abstract][Full Text] [Related]
19. Metabolic glycoengineering through the mammalian GalNAc salvage pathway. Pouilly S; Piller V; Piller F FEBS J; 2012 Feb; 279(4):586-98. PubMed ID: 22151230 [TBL] [Abstract][Full Text] [Related]
20. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma. Pousset D; Piller V; Bureaud N; Monsigny M; Piller F Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]